KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationCost Of RevenueCustomer Additions AnnualCustomers Count AnnualDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Taxes By RegionLong Lived AssetsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNo. Of Genes ShippedNo. Of Genes Shipped AnnualNo. Of Orders TotalNo. Of Orders Total AnnualNo. Of ShipmentsOpex As A % Of Total Revenue %OPEX SegregationOrder BreakdownProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By IndustryRevenue By Industry %Revenue By Industry AnnualRevenue By Industry Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue Mix From Repeat Customers %Shipped ProductsValue Of Orders
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Gross Profit (2018 - 2025)

Historic Gross Profit for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $54.0 million.

  • Twist Bioscience's Gross Profit rose 2598.51% to $54.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $202.1 million, marking a year-over-year increase of 3729.5%. This contributed to the annual value of $191.0 million for FY2025, which is 4323.47% up from last year.
  • As of Q4 2025, Twist Bioscience's Gross Profit stood at $54.0 million, which was up 2598.51% from $50.8 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Gross Profit registered a high of $54.0 million during Q4 2025, and its lowest value of $12.2 million during Q1 2021.
  • Over the past 5 years, Twist Bioscience's median Gross Profit value was $25.4 million (recorded in 2022), while the average stood at $29.7 million.
  • In the last 5 years, Twist Bioscience's Gross Profit soared by 19746.57% in 2021 and then plummeted by 1290.43% in 2023.
  • Twist Bioscience's Gross Profit (Quarter) stood at $15.0 million in 2021, then skyrocketed by 65.76% to $24.8 million in 2022, then rose by 16.78% to $29.0 million in 2023, then surged by 47.92% to $42.8 million in 2024, then rose by 25.99% to $54.0 million in 2025.
  • Its Gross Profit stands at $54.0 million for Q4 2025, versus $50.8 million for Q3 2025 and $51.3 million for Q2 2025.